Membranoproliferative Glomerulonephritis Type I: A Correlation Between Treated (138) and Untreated (108) Patients
Idiopathic membranoproliferative glomerulonephritis (MPGN) is a well defined histologic entity of unknown pathogenesis that leads to renal failure in the majority of patients, with renal survival of 50% after ten years from RB..
KeywordsPlatelet Inhibitor Therapeutical Group Membranoproliferative Glomerulonephritis Proliferative Glomerulonephritis Renal Survival
Unable to display preview. Download preview PDF.
- 1.McEnery, P. T., McAdams, A. J. and West, C. D. Medicine 5: 401–424, 1986.Google Scholar
- 2.A report of the international study of kidney disease in children. Alternate day steroid therapy in membrano-proliferative glomerulonephritis: a randomized controlled trial. Kidney Int. 21: 12, 1982 (A).Google Scholar
- 3.Tiller, D. J., Clarkson, A. R., Mathew, T., Thompson, N., Row, G., Lauer, C., Hobbs, J. and Seymour, A. Proc. 8th Congr. Nephrol. Athens 345–351, 1981.Google Scholar